DisclosureWe earn commission on partner links; ranking is set by our evidence-based methodology — not advertisers. Read policy

Photo: HealthVetted editorial render
Finasteride 1mg + Minoxidil 5%

Photo: HealthVetted editorial render
Saw palmetto, Ashwagandha, Marine collagen
| # | Product | Active ingredient | Starting price | FDA status | Score | |
|---|---|---|---|---|---|---|
| 1 | Hims Hair (Finasteride + Minoxidil) | Finasteride 1mg + Minoxidil 5% | Best ·$37/mo | approved | Top ·8.3 | See offer → |
| 2 | Nutrafol Men | Saw palmetto, Ashwagandha, Marine collagen | $88/mo | supplement | 7.0 | See offer → |
Hims Hair targets male-pattern baldness two ways at once. Finasteride blocks the enzyme 5-alpha-reductase, which converts testosterone into DHT, the hormone that shrinks genetically susceptible scalp follicles; lowering scalp DHT slows that miniaturization. Minoxidil works on a different pathway, widening blood vessels and prolonging the follicle's active growth (anagen) phase to reactivate dormant follicles and thicken existing hairs. Used together as a daily scalp spray, they aim to slow loss (finasteride) while stimulating regrowth (minoxidil).
Nutrafol Men is an oral nutraceutical (not a drug) that aims to address several contributors to thinning hair at once rather than acting on a single pathway. Standardized saw palmetto is included to mildly reduce conversion of testosterone to DHT, the hormone that shrinks genetically sensitive follicles; ashwagandha is an adaptogen meant to blunt stress hormones like cortisol; and curcumin, tocotrienols (vitamin E) and other antioxidants target oxidative stress and micro-inflammation around the follicle. Vitamins, minerals, hydrolyzed marine collagen (fish-derived) and amino acids supply building blocks for the hair shaft. The idea is to nudge follicles back toward the active growth (anagen) phase. Note that its DHT-lowering effect from saw palmetto is far weaker and less established than prescription finasteride, and the multi-ingredient design makes it hard to know which components, if any, drive results.
The active ingredients are individually well-validated. In the pivotal oral finasteride 1mg trials cited on the Propecia FDA label, 48% of men had increased hair count at 12 months versus 7% on placebo; in 5-year data, 48% showed increased growth, 42% had no further loss, and about 10% continued losing. For topical minoxidil, a 393-man, 48-week randomized trial found 5% minoxidil produced roughly 45% more regrowth than 2% minoxidil by target-area hair counts. Combining a 5-alpha-reductase inhibitor with minoxidil generally outperforms either alone. Important caveat: Hims' specific compounded 0.3% topical finasteride / 6% minoxidil spray has not been studied in large dedicated FDA trials, so its exact regrowth numbers are inferred from the individual drugs, not proven for this product.
The pivotal evidence is a 6-month, multi-center, randomized, double-blind, placebo-controlled trial in men with thinning hair, published in the Journal of Cosmetic Dermatology (Bhatia et al., 2025; PMC11701407). Of 112 enrolled, 85 completed per protocol (52 active, 33 placebo). Notably, the original objective primary endpoint—change in mean terminal hair count via Canfield HairMetrix—was abandoned because numerous protocol deviations at clinical sites rendered many measurements unusable, so only secondary outcomes are reported. At Day 180, blinded investigators rated hair growth "improved" in 79% of the active group versus 51% on placebo (p<0.01) and hair quality improved in 74% versus 54% (p=0.026). On a self-report questionnaire, 85% versus 55% felt the treatment slowed their hair loss (p<0.05) and 46% versus 24% were satisfied with hair on top (p<0.05). So the trial shows a real, statistically significant edge over placebo, but the surviving outcomes are subjective, the dropout (about 24%) was substantial, and the study was funded by Nutraceutical Wellness Inc. (Nutrafol's maker) with several authors employed by or paid as advisors to the company.
Local effects are most common: scalp itching, dryness, flaking, redness, or irritation from the alcohol/minoxidil base, plus possible unwanted facial hair if the product migrates. Minoxidil can cause a temporary early shed in the first weeks. Finasteride's known risks include decreased libido, erectile dysfunction, and ejaculation disorders (roughly 1-2% in oral trials, modestly above placebo). Serious or rarer concerns on the FDA finasteride label include depression, suicidal ideation, gynecomastia, and sexual side effects that can persist after stopping (sometimes called post-finasteride syndrome). Critically, in April 2025 the FDA alerted clinicians and consumers about compounded topical finasteride after reports of erectile dysfunction, anxiety, suicidal ideation, brain fog, depression, fatigue, insomnia, decreased libido, and testicular pain, many of which continued after discontinuation; topical use lowers but does not eliminate systemic absorption. Minoxidil can rarely cause dizziness or rapid heartbeat. Stop and seek care for chest pain, swelling, fainting, or mood changes.
Nutrafol Men is generally well tolerated. In the trial, eight possibly or probably related adverse events occurred in six subjects (three in the active group, three on placebo), all gastrointestinal—bloating, stomach irritation, diarrhea, intermittent nausea—with two participants withdrawing for moderate GI upset and no serious adverse events. Outside the trial, users occasionally report mild stomach upset, headache, or unwanted body or facial hair from general follicle stimulation. A key practical caution: the formula's biotin can interfere with lab tests (thyroid, troponin/cardiac, hormone panels), and the FDA has linked biotin interference to falsely low troponin results, including one reported death, so stop biotin-containing supplements before bloodwork (commonly advised at least 72 hours ahead) and tell your provider you take it. Botanical supplements such as saw palmetto and ashwagandha have rare case reports of liver issues; stop and see a doctor if you develop dark urine, jaundice, or upper-right abdominal pain. Dietary supplements are not reviewed by the FDA for safety and efficacy the way prescription drugs are.
As of 2026, the Hims topical finasteride + minoxidil spray starts around $35/month, with the lowest per-month price when billed and shipped on a longer (for example, multi-month) cycle. For comparison, Hims oral finasteride runs about $22/month and standalone minoxidil about $15/month. There may also be a low-cost or one-time medical consultation fee. These are cash-pay telehealth/compounded products, so insurance typically does not cover them; generic oral finasteride filled at a pharmacy with a prescription can sometimes be cheaper (often around $10-25/month with discount cards) for those who do not need the topical convenience.
As of 2026, Nutrafol Men typically runs about $88 for a one-time single bottle (one-month supply) and around $79/month on a standard monthly subscription (roughly a 10% saving), with larger discounts—commonly 15-25%—on prepaid 3-month or 6-month plans (a 3-month subscription is around $237, sometimes lower with deeper promotions). It is a dietary supplement, so it is not covered by health insurance and does not qualify for typical pharmacy discount cards; however, many FSA/HSA accounts may reimburse it, and it's sometimes sold through dermatology and med-spa offices. For comparison, generic finasteride and minoxidil—both FDA-approved with stronger regrowth evidence—often cost roughly $10-$30/month (frequently under $30 with pharmacy coupons), making Nutrafol a premium-priced choice. Prices vary by retailer and promotion, so confirm the current price at checkout.
Designed for adult men (typically 18+) with mild-to-moderate male-pattern hair loss, especially at the crown/vertex and frontal areas; earlier treatment generally protects more hair. It requires a telehealth medical evaluation before a clinician decides whether to prescribe it. Finasteride is not approved for and should not be used by women, and it must never be handled by anyone who is or may become pregnant because of the risk of birth defects in a male fetus. Avoid if you have a finasteride or minoxidil allergy; men planning to conceive, with a history of depression, or with liver or cardiovascular concerns should discuss the risks with a clinician first.
Best suited for adult men (typically 18+) with early-stage, self-perceived thinning or diffuse shedding who want a drug-free, over-the-counter approach and can wait 3-6 months for results. It is a supplement, not a cure for advanced male-pattern baldness. Note that it contains hydrolyzed marine collagen sourced from North Atlantic cod, so anyone with a fish allergy should avoid it (the manufacturer labels the product shellfish-, gluten-, and soy-free). Consult a doctor first if you take blood thinners, have liver disease, take medications affecting hormones, or have a hormone-sensitive condition. Pause biotin-containing supplements about 72 hours before any blood test, as biotin can skew thyroid, cardiac (troponin) and other lab assays. Pregnant or breastfeeding people and anyone under 18 should not use it without medical guidance. Always discuss new supplements with a clinician, especially if you take prescription drugs.
Nutrafol Men: Nutrafol Men is a daily botanical supplement (saw palmetto, ashwagandha, curcumin, vitamins) for men with thinning hair. A 2025 manufacturer-funded RCT found blinded investigators rated hair growth "improved" in 79% of users versus 51% on placebo at 6 months. It's drug-free and generally well-tolerated, but the evidence is modest and largely subjective, and it's weaker and pricier than finasteride or minoxidil. On balance, Hims Hair (Finasteride + Minoxidil) edges ahead in our scoring, but the right choice depends on your situation.
Editorial comparison, not medical advice. Discuss options with a qualified clinician. Individual results vary.